MDR-TB
Clinical trials for MDR-TB explained in plain language.
Never miss a new study
Get alerted when new MDR-TB trials appear
Sign up with your email to follow new studies for MDR-TB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 6-Month TB drug combo could replace Year-Long ordeal
Disease control Not yet recruitingThis study tests a new 6-month treatment called BPaLM for people with multidrug-resistant tuberculosis (MDR-TB) in France. The goal is to see if this shorter regimen works as well as the standard long treatment that can last over a year. About 55 adults with confirmed MDR-TB will…
Matched conditions: MDR-TB
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New drug combo aims to shorten tough TB treatment
Disease control Not yet recruitingThis study tests whether adding acetohydroxamic acid (AHA) to a short-course drug regimen can safely and effectively treat multidrug-resistant tuberculosis (MDR-TB). About 120 adults with confirmed MDR-TB will receive either AHA or a placebo along with standard short-course antib…
Matched conditions: MDR-TB
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 14, 2026 12:06 UTC